Voice AI screening launch

A worker’s voice is becoming a workplace test. MindBio Therapeutics said in April 2026 it is rolling out an artificial-intelligence system that screens for drug and alcohol intoxication from short speech samples. (mindbiotherapeutics.com) Voice biomarker technology works by turning speech into measurements. MindBio says its system extracts more than 140 acoustic features from a spoken phrase, compares them with reference models and returns a sobriety assessment with a confidence score in seconds. (mindbiotherapeutics.com) The company says its models were trained on more than 50 million data points and claims more than 88% intoxication-detection accuracy and more than 85% blood-alcohol-content estimation accuracy. MindBio is pitching the product for “zero-tolerance regulated industries” and says kiosk hardware is part of the enterprise rollout. (mindbiotherapeutics.com) MindBio has spent the first months of 2026 moving the product toward employers. Its website lists January and February announcements on United States demonstrations, mining-industry commercialization and “large-scale deployment” through an integrated edge artificial-intelligence hardware and software platform. (mindbiotherapeutics.com) The launch lands in a workplace-testing system built around biological samples, not speech. The Substance Abuse and Mental Health Services Administration says workplace drug-testing programs are designed to detect the presence of alcohol, illicit drugs or certain prescription drugs, and that testing must comply with local, state and federal law. (samhsa.gov) Federal transportation rules are even more specific. The Department of Transportation’s testing procedures in 49 CFR Part 40 define alcohol testing around breath and drug testing around regulated specimen-based procedures for safety-sensitive workers. (ecfr.gov) That leaves a practical question for employers: whether a voice screen is being used as a regulated test, a preliminary flag, or a separate health assessment. The Equal Employment Opportunity Commission says the Americans with Disabilities Act limits when employers may require medical examinations or make disability-related inquiries during employment. (eeoc.gov) Researchers in voice biomarkers have warned for years that promising signals are not the same as deployable diagnostics. A 2021 review in *Digital Biomarkers* said vocal biomarkers need validation against gold-standard measures before they can move safely from small studies into clinical use. (ncbi.nlm.nih.gov) Regulators are also still building the road for software that makes health judgments. The Food and Drug Administration says medical-device software developers may need to navigate premarket pathways and related guidance depending on how a product is intended to be used. (fda.gov) MindBio says its platform preserves privacy through federated learning and regulatory compliance, but its public materials do not spell out how employee voiceprints, confidence thresholds, false positives or appeals would work in a workplace discipline process. The company is now trying to turn a spoken phrase into a screening tool, and employers will have to decide whether that is a monitor, a medical exam or just an early warning. (mindbiotherapeutics.com)